These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 27558098)
1. Mitigation of Initial Cardiodynamic Effects of the S1P Juif PE; Hoch M; Vaclavkova A; Krause A; Bush J; Dingemanse J J Clin Pharmacol; 2017 Mar; 57(3):401-410. PubMed ID: 27558098 [TBL] [Abstract][Full Text] [Related]
2. Multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ponesimod, an S1P1 receptor modulator: favorable impact of dose up-titration. Brossard P; Scherz M; Halabi A; Maatouk H; Krause A; Dingemanse J J Clin Pharmacol; 2014 Feb; 54(2):179-88. PubMed ID: 24408162 [TBL] [Abstract][Full Text] [Related]
3. Three different up-titration regimens of ponesimod, an S1P1 receptor modulator, in healthy subjects. Scherz MW; Brossard P; D'Ambrosio D; Ipek M; Dingemanse J J Clin Pharmacol; 2015 Jun; 55(6):688-97. PubMed ID: 25612299 [TBL] [Abstract][Full Text] [Related]
4. Cardiodynamic Interactions between Two S1P Juif PE; Ufer M; Dingemanse J Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31266149 [TBL] [Abstract][Full Text] [Related]
5. Effect of ponesimod, a selective S1P1 receptor modulator, on the QT interval in healthy individuals. Hoch M; Darpo B; Brossard P; Zhou M; Stoltz R; Dingemanse J Basic Clin Pharmacol Toxicol; 2015 May; 116(5):429-37. PubMed ID: 25287214 [TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of ponesimod, a selective S1P₁ receptor modulator, after uptitration to supratherapeutic doses in healthy subjects. Hoch M; D'Ambrosio D; Wilbraham D; Brossard P; Dingemanse J Eur J Pharm Sci; 2014 Oct; 63():147-53. PubMed ID: 25046167 [TBL] [Abstract][Full Text] [Related]
7. Effects of ponesimod, a selective S1P1 receptor modulator, on the pharmacokinetics of a hormonal combination contraceptive. Reyes M; Brossard P; Chassard D; Hoch M; Dingemanse J Eur J Clin Pharmacol; 2014 Mar; 70(3):287-93. PubMed ID: 24362488 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator, in the first-in-human study. Brossard P; Derendorf H; Xu J; Maatouk H; Halabi A; Dingemanse J Br J Clin Pharmacol; 2013 Dec; 76(6):888-96. PubMed ID: 23594176 [TBL] [Abstract][Full Text] [Related]
9. Desensitization by progressive up-titration prevents first-dose effects on the heart: guinea pig study with ponesimod, a selective S1P1 receptor modulator. Rey M; Hess P; Clozel M; Delahaye S; Gatfield J; Nayler O; Steiner B PLoS One; 2013; 8(9):e74285. PubMed ID: 24069292 [TBL] [Abstract][Full Text] [Related]
10. Absolute Bioavailability of Ponesimod, a Selective S1P Boehler M; Juif PE; Hoch M; Dingemanse J Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):129-134. PubMed ID: 26883438 [TBL] [Abstract][Full Text] [Related]
11. Biocomparison of Three Formulations of the S1P1 Receptor Modulator Ponesimod in Healthy Subjects. Juif PE; Hoch M; D'Ambrosio D; Dingemanse J Drugs R D; 2015 Jun; 15(2):203-10. PubMed ID: 25939333 [TBL] [Abstract][Full Text] [Related]
12. Effects of multiple-dose ponesimod, a selective S1P Jurcevic S; Juif PE; Hamid C; Greenlaw R; D'Ambrosio D; Dingemanse J Drug Des Devel Ther; 2017; 11():123-131. PubMed ID: 28096659 [TBL] [Abstract][Full Text] [Related]
13. Effects of ethnicity and sex on the pharmacokinetics and pharmacodynamics of the selective sphingosine-1-phosphate receptor 1 modulator ponesimod: a clinical study in Japanese and Caucasian subjects. Reyes M; Hoch M; Brossard P; Dingemanse J Pharmacology; 2014; 94(5-6):223-9. PubMed ID: 25402365 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of ponesimod, a selective S1P1 receptor modulator, on blood-circulating human T cell subpopulations. D'Ambrosio D; Steinmann J; Brossard P; Dingemanse J Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):103-9. PubMed ID: 25519470 [TBL] [Abstract][Full Text] [Related]
15. Safety, pharmacokinetics, pharmacodynamics, and bioavailability of GSK2018682, a sphingosine-1-phosphate receptor modulator, in healthy volunteers. Xu J; Gray F; Henderson A; Hicks K; Yang J; Thompson P; Oliver J Clin Pharmacol Drug Dev; 2014 May; 3(3):170-8. PubMed ID: 27128606 [TBL] [Abstract][Full Text] [Related]
16. Modeling the Effect of the Selective S1P Lott D; Krause A; Seemayer CA; Strasser DS; Dingemanse J; Lehr T Pharm Res; 2017 Mar; 34(3):599-609. PubMed ID: 28028771 [TBL] [Abstract][Full Text] [Related]